Upcoming IPOs This Week (Feb 16–Feb 20): Gaudium IVF Mainboard Issue and 2 SME IPOs to Open

India’s initial public offerings continues as a fresh set of public issues is scheduled to open across both the mainboard and SME segments during the week of February 16 to February 20.

Investor focus is expected to remain on new listings as companies from healthcare and industrial manufacturing sectors tap capital markets, reflecting sustained momentum in IPO participation.

During the week, Gaudium IVF will launch its mainboard IPO, while Fractal Industries and Yashhtej Industries (India) will open SME issues for subscription.

Upcoming IPOs: Key Details (Feb 16–Feb 20, 2026)

Mainboard IPO

1. Gaudium IVF IPO

Gaudium IVF IPO is a book-built issue comprising 2.09 crore shares, including a fresh issue of 1.14 crore shares and an offer for sale of 0.95 crore shares.

The company is scheduled for listing on BSE and NSE with a tentative listing date of February 27, 2026. The price band for the issue is yet to be announced.

Sarthi Capital Advisors Pvt. Ltd. is acting as the book-running lead manager, while Bigshare Services Pvt. Ltd. has been appointed as the registrar to the issue.

SME IPOs

1. Fractal Industries IPO

Fractal Industries IPO is a book-built issue aggregating ₹49.00 crore, consisting entirely of a fresh issue of 0.23 crore shares.

The allotment is expected to be finalised on February 19, 2026, with listing on the BSE SME platform tentatively scheduled for February 23, 2026.

The price band for the IPO has been fixed at ₹205 to ₹216 per share.

2. Yashhtej Industries (India) IPO

Yashhtej Industries (India) IPO is a fixed-price issue worth ₹88.88 crore, comprising entirely a fresh issue of 0.81 crore shares.

The allotment is expected to be finalised on February 23, 2026, and the shares are set to list on the BSE SME platform with a tentative listing date of February 25, 2026.

The IPO price has been fixed at ₹110 per share, with an application lot size of 1,200 shares.

Conclusion

With IPOs opening across healthcare and industrial segments, investor attention is expected to remain focused on subscription demand and listing prospects. 

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.

Investments in the securities market are subject to market risks, read all the related documents carefully before investing.